IL132629A0 - Protease inhibitors - Google Patents

Protease inhibitors

Info

Publication number
IL132629A0
IL132629A0 IL13262998A IL13262998A IL132629A0 IL 132629 A0 IL132629 A0 IL 132629A0 IL 13262998 A IL13262998 A IL 13262998A IL 13262998 A IL13262998 A IL 13262998A IL 132629 A0 IL132629 A0 IL 132629A0
Authority
IL
Israel
Prior art keywords
protease inhibitors
protease
inhibitors
Prior art date
Application number
IL13262998A
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of IL132629A0 publication Critical patent/IL132629A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06139Dipeptides with the first amino acid being heterocyclic
IL13262998A 1997-04-29 1998-04-29 Protease inhibitors IL132629A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4506797P 1997-04-29 1997-04-29
PCT/US1998/008740 WO1998048799A1 (en) 1997-04-29 1998-04-29 Protease inhibitors

Publications (1)

Publication Number Publication Date
IL132629A0 true IL132629A0 (en) 2001-03-19

Family

ID=21935831

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13262998A IL132629A0 (en) 1997-04-29 1998-04-29 Protease inhibitors

Country Status (18)

Country Link
EP (1) EP1019046A4 (en)
JP (1) JP2002504097A (en)
KR (1) KR20010020391A (en)
CN (1) CN1261276A (en)
AR (1) AR012622A1 (en)
AU (1) AU7365198A (en)
BR (1) BR9809333A (en)
CA (1) CA2287989A1 (en)
CO (1) CO4940477A1 (en)
HU (1) HUP0001294A3 (en)
IL (1) IL132629A0 (en)
MA (1) MA26487A1 (en)
NO (1) NO995268L (en)
PE (1) PE69099A1 (en)
PL (1) PL337725A1 (en)
TR (1) TR199902703T2 (en)
WO (1) WO1998048799A1 (en)
ZA (1) ZA983522B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999032121A1 (en) 1997-12-19 1999-07-01 Smithkline Beecham Corporation Compounds of heteroaryl substituted imidazole, their pharmaceutical compositions and uses
US6100282A (en) * 1998-01-02 2000-08-08 Hoffman-La Roche Inc. Thiazole derivatives
MA26618A1 (en) * 1998-04-09 2004-12-20 Smithkline Beecham Corp PHARMACEUTICAL COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MALARIA
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
AU1909200A (en) 1998-11-04 2000-05-22 Smithkline Beecham Corporation Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
CO5150165A1 (en) * 1998-11-13 2002-04-29 Smithkline Beecham Plc PROTEASE INHIBITORS: KATEPSIN K TYPE
US20030144175A1 (en) 1998-12-23 2003-07-31 Smithkline Beecham Corporation Protease inhibitors
EP1232155A4 (en) 1999-11-10 2002-11-20 Smithkline Beecham Corp Protease inhibitors
US6583137B1 (en) 1999-11-10 2003-06-24 Smithkline Beecham Corporation Protease inhibitors
JP2003513924A (en) 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション Protease inhibitor
AU1650501A (en) * 1999-12-03 2001-06-12 Ono Pharmaceutical Co. Ltd. 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
US6797720B2 (en) 1999-12-03 2004-09-28 Ono Pharmaceutical Co., Ltd. 1,3,4-oxadiazoline derivative and an agent comprising its derivative as active ingredient
NZ520588A (en) 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
EP1465862A1 (en) 2002-01-17 2004-10-13 SmithKline Beecham Corporation Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
JP2006503810A (en) * 2002-07-04 2006-02-02 アベンティス・ファーマ・ソシエテ・アノニム Novel acyl hydrazinothiophene derivatives, their preparation, their use as pharmaceuticals, pharmaceutical compositions and novel uses.
KR100962972B1 (en) 2002-07-26 2010-06-09 주식회사유한양행 1-phenylpiperidin-3-one derivatives and processes for the preparation thereof
WO2011015524A2 (en) * 2009-08-03 2011-02-10 Bayer Cropscience Ag Fungicide heterocycles derivatives
AU2013305759C1 (en) * 2012-08-23 2018-01-18 Janssen Biopharma, Inc. Compounds for the treatment of paramoxyvirus viral infections
SG11201600977XA (en) 2013-08-21 2016-03-30 Alios Biopharma Inc Antiviral compounds
MA41614A (en) 2015-02-25 2018-01-02 Alios Biopharma Inc ANTIVIRAL COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990067184A (en) * 1995-10-30 1999-08-16 스튜어트 알. 수터, 스티븐 베네티아너, 피터 존 기딩스 Protease inhibitor

Also Published As

Publication number Publication date
HUP0001294A2 (en) 2001-04-28
JP2002504097A (en) 2002-02-05
HUP0001294A3 (en) 2001-06-28
EP1019046A1 (en) 2000-07-19
BR9809333A (en) 2000-07-04
WO1998048799A1 (en) 1998-11-05
PL337725A1 (en) 2000-08-28
KR20010020391A (en) 2001-03-15
CA2287989A1 (en) 1998-11-05
CO4940477A1 (en) 2000-07-24
TR199902703T2 (en) 2000-02-21
ZA983522B (en) 1998-10-29
EP1019046A4 (en) 2002-11-27
CN1261276A (en) 2000-07-26
PE69099A1 (en) 1999-09-26
AU7365198A (en) 1998-11-24
MA26487A1 (en) 2004-12-20
NO995268D0 (en) 1999-10-28
AR012622A1 (en) 2000-11-08
NO995268L (en) 1999-11-15

Similar Documents

Publication Publication Date Title
ZA983843B (en) Protease inhibitors
PL336589A1 (en) Serinic protease inhibitors
PL349192A1 (en) Protease inhibitors
ZA98376B (en) Sulfamide-metalloprotease inhibitors
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL328307A1 (en) Serinic protease inhibitors
EP0744948A4 (en) Protease inhibitors
HUP0002247A3 (en) Protease inhibitors
ZA983841B (en) Protease inhibitors
EP1093367A4 (en) Protease inhibitors
IL132629A0 (en) Protease inhibitors
ZA988479B (en) Protease inhibitors
PL328875A1 (en) Serinic protease inhibitors
PL328223A1 (en) Aspartil protease inhibitors
EP1067894A4 (en) Protease inhibitors
EP1079821A4 (en) Protease inhibitors
ZA988064B (en) Protease inhibitors
HK1041690A1 (en) Protease inhibitors
EP1086083A4 (en) Protease inhibitors
EP0975612A4 (en) Protease inhibitors
IL132998A0 (en) Vif-derived hiv protease inhibitors
ZA983097B (en) Protease inhibitors
ZA977032B (en) Protease inhibitors
GB9420277D0 (en) Protease inhibitors
GB9727371D0 (en) Inhibitors